이 세 가지 화장실 감지 건강 기술은 미국에서 임상 테스트됩니다, 이스라엘과 일본

이 세 가지 화장실 감지 건강 기술은 미국에서 임상 테스트됩니다, 이스라엘과 일본

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 6월. The technology gains life-saving medical insights by analysing human excrement. 이 회사는 의료용 화장실 센서 요소를 다루는 일련의 3개 특허를 출원했습니다..

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, 유럽, 일본과 중국.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, 아웃센스의 기술은 위장관을 따라 혈액의 출처를 식별할 수 있다.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

OutSense CEO Yfat Scialom에 따르면, who predicts that “디지털 의학의 폭발과 함께, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, 염증성 장 질환 및 요로 감염.

Its solution consists of a multispectral optical sensor, WiFi 연결을 포함하는 광원 및 자율 검사 장치. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. 샘플링된 혈액에서 얻은 정보, 출혈부터 배설까지의 시간에 대한 추가 분석과 결합, 출혈 병리에 대한 세부 정보를 제공합니다.. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense는 CommuniCare를 발표했습니다., 이상의 규모를 갖춘 대규모 의료 회사 90 healthcare facilities in the US, 올해부터 기술 시험을 시작할 예정. 이번 파일럿 외에도, OutSense also plans to conduct clinical trials in Israel and Japan.

더 많은 뉴스를 방문하세요 Viga.cc 뉴스